Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing...

20
Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson, Kala Mohandas, Evan Himchak, Ronald Walsh May 5, 2017

Transcript of Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing...

Page 1: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson, Kala Mohandas, Evan Himchak, Ronald Walsh

May 5, 2017

Page 2: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Abbreviations

T/R

Simple transfusion and/ or red cell exchange

Post-HCT

Hematocrit immediately after the T/R

Post- HbS

Hemoglobin S level immediately after the T/R

Pre – HbS

Hemoglobin S level immediately before the T/R

F/u- HbS

= Pre-HbS of next T/R

Highest HbS level between 2 consecutive T/Rs

FCR

Fraction of cell remaining

calculated based on the desired Post-HbS

FCR = post-HbS/ pre-HbS

Page 3: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Background RCE Targets for SCA Patients

Clinical improvement

Post-HCT

≤ 30% traditionally

FCR

FCR = post-HbS/ pre-HbS

Post-HbS ≤ 30% traditionally

Page 5: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

New Challenge

How to maintain next pre-HbS ≤30% ?

Expert recommendation – none

Literature/ evidence – none

Thoughts: Monthly T/R with F/u-HbS ≤30%

- But how???

Page 6: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

How to maintain HbS <30%?

Current T/ R approaches for pediatric SCA pts:

Empirical

↓ post – HbS (i.e. post-T/R-HbS)

How low? 10-15%, or 15-20%

Or ↑ post-HCT

How much? Up to 36%

Why? Suppress erythropoiesis

For pts of how old?

Some recommend for all the ped SCA pts, up to 20 y/o

Evidence-based

None

Page 7: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Our Study - Aims

↓ post – HbS How to predict F/u-HbS from post-HbS?

Can we predict it by calculation?

To identify a threshold

which keeps F/u HbS < 30%

↑ post-HCT

To determine if raising post-HCT to 30-36% can suppress F/u- HbS to < 30%

If yes, how to predict F/u HbS < 30% from post-HCT?

Page 8: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Data Inclusion Criteria

Patients of genotype HbSS

Chronic monthly T/R

i.e. ~ 1 month (20-45 days) between 2 consecutive T/R events

Or a non-monthly T/R AND a F/u-HbS ~1 month later

AND no T/R event in between the post-HbS and the F/u HbS

June 2014 – Dec. 2015

Each event has at least a set of 3 documented parameters: post- HCT, and post-HbS, and F/u-HbS

To maximize the sample size for proof of concept, this study includes both pediatric and adult patients

Page 9: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Data Exclusion Criteria

Patients with other hemoglobinopathies rather than genotype HbSS

Events with incomplete data points

Post-HbS > 30%

Post-HCT > 36%

SCA patients after allo-Stem Cell TxP

Page 10: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Results

47 SCA patients

26 children, 21 adults

17 females, 30 males

247 T/R events

74 Pediatric events 173 adult events

190 events with HCT <30% 57 events with HCT 30-36%

Page 11: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Results T

ab

le 1

. C

ha

racte

risti

cs o

f T

/R

SC

A p

ati

en

ts

Page 12: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Results

- A moderate correlation - Lowering post-HbS lowers F/u-HbS. - However, the value of post-HbS does not predict F/u-HbS with accuracy.

Figure 1. Linear Regression Analysis

y = 1.03 x + 18.41 R² = 0.444

-5

5

15

25

35

45

55

65

0 10 20 30

F/u

-Hb

S (

%)

Post-HbS (%)

Post-HbS vs. F/u-HbS

Page 13: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Figure 2. Linear Regression Analysis

_ Nearly no correlation between Post-HCT and F/u-HbS. _ Raising post-HCT does not lower F/u-HbS.

Results

Page 14: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Results (Table 2, comparing F/u-HbS levels)

Post-HbS ≤10% effectively keeps F/u-HbS <30%;

Raising post-HCT to 30-36% does not lower F/u-HbS to <30%

Page 15: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Results Table 3. Comparing frequency of 2 F/u-HbS levels in different post-HbS categories and post-HCT groups

Page 16: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Results

Table 4. Frequency comparison of selected F/u-HbS levels in various post-HbS categories

Page 17: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Results Table 5. Frequency comparison of selected F/u-HbS levels in SCA patients

Pediatric patients Adult patients

A similar trend in both Pediatric and adult SCA patients. (1) Post-HbS ≤10% keeps most of F/u-HbS <30% (2) Empirical Post-HbS 10-15% keeps only half of F/u-HbS <30% (3) Empirical Post-HbS 15-20% or above only keeps less than 10% of F/u-HbS <30% (4) Traditional Post-HbS 20-30% only keeps ≤ 85% of F/u-HbS <50%.

Page 18: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Conclusions Identified a threshold

Post-HbS ≤10%

to keep most of F/u-HbS <30%

for pediatric SCA pts

Demonstrated that empirically raising post-HCT to 30-36% fails to lower F/u-HbS.

Identified an additional threshold

Post-HbS ≤20%

to keep nearly 100% of F/u-HbS <50%

for “refractory” adult SCA patients

who sometimes still have SCD crisis

when on monthly T/R

To our knowledge, this is the first evidence-based study demonstrating these results.

Page 19: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Our Recommendations

Lower post-HbS to 5-10% for monthly T/R

for pediatric HgSS SCA patients

to maintain F/u-HbS < 30%

DO NOT raise post-Hct to >30-36%

It fails to suppress HbS production !!

It increases the risks of hyperviscosity and iron overload

Lower post-HbS to ≤ 20%

for refractory adult HgSS patients

to ensure F/u- HbS < 50%

A prospective randomized study

Page 20: Ding Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa ...c.ymcdn.com/sites/ · PDF fileDing Wen Wu, Rachel Friedmann, Joan Uehlinger, Sadiqa Karim, Etan Marks, Angie Bonzon-Adelson,

Acknowledgement

Deepa Manwani, MD

Pediatric Hematology

Yungtai Lo, PhD, Statistician

Gurbakhash Kaur, MD

Hematology/ Oncology